固体脂质纳米粒子作为一种创新的脂质药物输送系统
Suchita Waghmare1, Rohini Palekar1, Lata Potey2
1Department of Pharmaceutical Sciences, Rashtrasant Tukadoji Maharaj Nagpur University, Nagpur, Maharashtra, 440033, India.
Pharmaceutical nanotechnology
|February 6, 2024
概括
固体脂质纳米颗粒 (SLN) 与传统的药物输送系统相比,由于其简单的生产,可扩展性和生物相容性而具有优势. 本综述探讨了SLN,涵盖了它们的类型,制备和在药物输送中的应用.
科学领域:
- 制药科学 制药科学
- 纳米技术纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 传统的药物配方存在局限性.
- 基于脂质的药物输送系统正在获得突出地位.
- 固体脂质纳米粒子 (SLNs) 是一个重点领域.
研究的目的:
- 审查固体脂质纳米载体 (SLN) 的重要性.
- 讨论SLN的优点和缺点.
- 探索用于药物输送的SLN技术的各种方面.
主要方法:
- 关于固体脂质纳米载体的文献综述.
- 分析SLN类型,成分和制备方法.
- 检查药物释放机制,表征和注射途径.
主要成果:
- SLN提供了诸如生产方便,可扩展性,生物相容性和生物降解性等优势.
- SLN 可以针对特定的管理路径进行定制.
- 突出了SLN在各种药物输送系统中的多种应用.
结论:
- 固体脂质纳米颗粒在药物输送方面是一个有前途的进步.
- 该审查提供了SLN技术的全面概述.
- SLN 显示了改善药物有效性和药物输送的巨大潜力.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...


